Department: Leadership
-
Susan Hensley, MS, RAC
With over twenty-five years of experience in biopharmaceutical Regulatory Affairs, Susie joined GeoVax in 2024. Having held prior leadership roles with Vaxxinity, Takeda, Novavax, Parexel, and Human Genome Sciences, Susie brings a broad view across the regulatory landscape and has experience in regulatory strategy development, global submission management, regulatory oversight of clinical trials, and the…
-
Mary J. Hauser, PhD
Dr. Hauser joined GeoVax in 2018 as a scientist and has since accepted the role of directing research programs to preclinical endpoint. Mary brings expertise in pathogen host interactions with over 15 years training on the topic. Her prior research in Virology & Immunology at University of Georgia and Virginia Tech Carilion Research Institute involved…
-
Arban Domi, PhD
Dr. Domi has 20+ years of experience in poxviruses and vaccine development and was the inventor of the first infectious clone of a poxvirus genome cloned in bacteria. He received his PhD from the University of Paris, followed by post-doctoral training at the Jacques Monod Institute of Molecular Biology in Paris. Both his thesis and…
-
David A. Dodd
David Dodd is a recognized leader with highly successful experience and expertise in transforming and restructuring public and private companies, establishing strong governance processes and operational discipline, resulting in operational improvements, significant revenue and enterprise value growth. During his career, he has overseen the approval of over 10 NDAs, over 15 acquisitions/divestitures, in excess of…